|
VY1706 Low dose Clinical Trials
1 actively recruiting trial across 1 location
Maitland, Florida1 trial
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease
K2 Medical Research, LLC
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.